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Abstract
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Interoceptive conditioning contributes to the tenacity of nicotine dependence. Previous research
investigating nicotine as an interoceptive stimulus has typically employed administration of a
single training dose of nicotine over an extended time. This approach has allowed for careful study
of the nicotine stimulus. In humans, the nicotine stimulus is unlikely to be fixed across learning
episodes. Thus, from a translational perspective, systematic variation of nicotine dose in training
might better approximate interoceptive conditioning in humans. Notably, training with a class or
set of discrete exteroceptive stimuli (e.g., different pictures of cars) produces interesting
behavioral differences relative to training with a single stimulus. The present study sought to
determine whether similar differences would occur if a set of nicotine stimuli were used in place
of a single dose. To investigate this question, one group of male Sprague-Dawley rats was trained
on a discriminated goal-tracking task with a set of nicotine doses (0.05, 0.125, 0.2, 0.275, and 0.35
mg/kg). A second group received the standard protocol of training with a single nicotine dose (0.2
mg/kg). On each nicotine session, there was intermittent access to liquid sucrose (26%) in a
conditioning chamber. On intermixed saline sessions, sucrose was withheld. We examined
acquisition, subsequent extinction, transfer of extinction, nicotine generalization, and
mecamylamine blockade. Both groups reliably discriminated between nicotine and saline sessions,
were sensitive to non-reinforcement, displayed transfer of extinction, demonstrated dosedependent nicotine generalization, and responding was blocked by mecamylamine. There were no
significant differences between the two groups. The unique nature of an interoceptive
pharmacological stimulus and the challenges posed for studying the impact of training with a set
of interoceptive stimuli are discussed.
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Introduction
Learning involving interoceptive drug stimuli likely contributes to the tenacity of tobacco
dependence (Besheer et al, 2004; Bevins and Murray, 2011; Bevins and Palmatier, 2004;
Glautier et al, 1996; Troisi, 2006). Elucidating the contribution of interoceptive conditioning
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to drug addiction is critical to advance our understanding and treatment of addiction (Alessi
et al, 2002; Bevins et al, 2012; Clements et al, 1996; Glautier et al, 1996; Wise et al, 2008).
One preclinical model used to study nicotine interoceptive conditioning is the discriminated
goal-tracking task with rats (Besheer et al, 2004; Charntikov et al, 2012; Murray and
Bevins, 2007a, b; Polewan et al, 2013; Reichel et al, 2010; Struthers et al, 2009; Wilkinson
et al, 2006). In this task, systemic nicotine is repeatedly paired with an appetitive event such
as intermittent access to sucrose. On intermixed sessions, saline is administered instead of
nicotine and sucrose is not available. Following repeated pairings, the nicotine stimulus
enters into a conditioned association with the sucrose (Pittenger and Bevins, 2013). This
conditioned association is evidenced by greater ‘anticipatory’ head entries into the dipper
receptacle [termed goal-tracking; (Farwell and Ayres, 1979)], following nicotine
administration.
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The discriminated goal-tracking task has been used for parametric assessment of behavioral
factors affecting interoceptive conditioning with a nicotine stimulus. For example, the
magnitude of the goal-tracking conditioned response controlled by the nicotine stimulus
increases as the concentration of sucrose increases from 4% to 32% (w/v) (Murray et al,
2009b). Further, the acquisition of conditioning is accelerated by increasing the number of
sucrose presentations per session (Wilkinson et al, 2006). Having a higher density of
reinforcement in acquisition also produces a goal-tracking response that is more persistent
when sucrose deliveries are ceased [i.e., extinction (Wilkinson et al, 2006)]. Murray and
Bevins (2007b) used the discriminated goal-tracking task to investigate how the
interoceptive effects of nicotine vary as a function of training dose. Rats were split into
separate groups and trained with an interoceptive stimulus of 0.1, 0.2, or 0.4 mg/kg nicotine.
Although the rate of acquisition was similar across doses, conditioned responding controlled
by the higher dose of nicotine (0.4 mg/kg) was more resistant to extinction. In addition,
when the time between nicotine administration and the assessment of conditioned
responding was varied, the 0.4 mg/kg group displayed responding at longer injection-toplacement-intervals, indicating that higher doses continue to control behavior longer than
the lower doses. Further, the nicotine dose-effect curves varied with training dose. That is,
lower doses of nicotine evoked greater responding in rats trained with the lowest training
dose [0.1 mg/kg; (Murray et al, 2007b)]. These findings indicate that interoceptive
conditioning with the nicotine stimulus tends to follow general principles of learning
(Bevins et al, 2011) and that salience (dose) of the nicotine stimulus is important (cf.
Polewan et al, 2013).

NIH-PA Author Manuscript

The nicotine stimulus can be conceptualized as a complex internal stimulus, with different
doses varying in perceptibility, as well as in the neurobiological elements that likely
compose the stimulus (Bevins et al, 2012; Bevins et al, 2011). As briefly summarized in the
previous paragraph, differences across doses of the nicotine stimulus manifest themselves in
a variety of ways—persistence of responding in extinction, longer lasting control of
responding, etc. Studies to date investigating interoceptive conditioning within the
discriminated goal-tracking task have used a single unvarying dose of nicotine as the
training stimulus. That is, if 0.4 mg/kg was selected as the training dose, then every
acquisition and subsequent training session had this 0.4 mg/kg nicotine dose as the stimulus
paired with access to sucrose. The present study examined if controlled variation of the
nicotine stimulus (dose) that was paired with intermittent access to sucrose would alter
expression of interoceptive conditioning relative to a standard condition that receives the
same training dose throughout.
Varying the training dose of nicotine across sessions is of considerable interest for at least 2
reasons. First, from a translational perspective, a conditioning history with varying doses of
nicotine may more closely resemble that experienced by humans. For instance, an individual
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might get interrupted on a work break and only have had a couple puffs on a cigarette. Later
in the day, the same person may have several cigarettes on the commute home from work.
Whether or not such variation affects expression of interoceptive conditioning is a question
of great interest that may help inform researchers on how to increase the translational
relevance of current animal models of interoceptive drug conditioning. Second, from an
empirical and theoretical perspective, there are data showing that what is learned can vary
depending on whether one stimulus, or a class (set) of stimuli, are used in training (Bhatt,
1988; Herrnstein, 1979; Herrnstein and deVillers, 1980b; Herrnstein and Loveland, 1964;
Siegel and Honig, 1970; Stemmer, 1980; Wasserman and Bhatt, 1992b; Watanabe et al,
1995). Past research in this area, however, has focused on distinct exteroceptive stimuli such
as pictures of trees, people, and even paintings. Utilizing a class of interoceptive
pharmacological stimuli has not received the same attention [see the Discussion for more on
this point and on studies using early onset drug stimuli and drug mixtures; Greeley et al,
(1984); Kim et al (1999); Mariathasan and Stolerman (1993); Mariathasan et al, (1996);
Siegel, (2005); Siegel and Ramos, (2002); Stolerman et al, (2011); Stolerman and White,
(1996); White and Stolerman (1996); Wise et al, (2008)]. The present research investigated
how administration of a range of nicotine doses (0.05, 0.125, 0.2, 0.275, and 0.35 mg/kg)
affected acquisition and altered subsequent extinction, nicotine generalization, and
mecamylamine blockade when compared to a group that received a fixed dose (0.2 mg/kg)
of nicotine during training.
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2. Material and Methods
2.1 Subjects
Sixteen experimentally naive male Sprague-Dawley rats ordered at 275-299 g from Harlan
(Indianapolis, IN, USA) were housed individually in clear polycarbonate cages (48.3 × 26.7
× 20.3 cm; length × width × height) lined with wood shavings. Rats had ad libitum access to
water in home cages. Following acclimation to the colony, rats were handled for a minimum
of 2 min per day for 3 consecutive days before access to food (Harlan Teklad Rodent Diet)
was restricted to maintain rats at 85% of their free-feeding body weight. The colony room
was temperature and humidity controlled. All experimental sessions were conducted during
the light portion of a 12 hour light/dark cycle. Protocols were approved by the University of
Nebraska-Lincoln Institutional Animal Care and Use Committee.
2.2 Apparatus
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Eight conditioning chambers (ENV-008CT; Med Associates, Inc., Georgia, VT, USA)
measuring 30.5 × 24.1 × 21.0 (length × width × height) cm were enclosed in sound and light
attenuating cubicles fitted with an exhaust fan to provide airflow and mask noise. The front,
back, and ceiling of the chambers were clear polycarbonate; side walls were aluminum. A
recessed receptacle (5.2 × 5.2 × 3.8 cm; length × width × depth) was on one of the side
walls. A dipper arm raised a 0.1-ml cup of sucrose (26% w/v) into the receptacle. To record
head entries into the dipper receptacle, each chamber was equipped with an emitter/detector
unit placed 1.2 cm into the recessed receptacle and 3 cm above the rod floor of the chamber.
A personal computer with Med Associates interface and software (Med-PC for Windows,
version IV) controlled sucrose deliveries and recorded dipper entries.
2.2 Drugs
(-)-Nicotine hydrogen tartrate and mecamylamine hydrochloride were purchased from
Sigma (St. Louis, MO, USA). Nicotine was dissolved in 0.9% saline and adjusted to a pH of
7.0 ± 0.2 using a dilute NaOH solution. Nicotine doses are reported as the base form.
Mecamylamine was dissolved in saline; doses are reported as the salt form. All injections
were administered subcutaneous (SC) at a volume of 1 ml/kg.
Pharmacol Biochem Behav. Author manuscript; available in PMC 2014 December 01.
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To minimize the initial locomotor suppressant effects of nicotine, rats received daily
injections of 0.4 mg/kg nicotine in their home cages for the 3 days immediately before the
start of the experiment (Bevins et al, 2001). At the start of the experiment, rats were divided
into 2 groups [stable-dose (StD) or varying-dose (VD)] before the start of acquisition
sessions. Discrimination training consisted of 40 daily sessions; 20 nicotine sessions and 20
saline sessions were intermixed. The order of the sessions was pseudo-randomly assigned
with the stipulation that rats received no more than 2 consecutive days with the same type of
session. Nicotine sessions for the StD group consisted of a 0.2 mg/kg SC nicotine injection 5
min before placement in the chamber for a 20-min session. Nicotine sessions for the VD
group consisted of a SC injection with 0.05, 0.125, 0.2, 0.275, or 0.35 mg/kg nicotine. The
order of dose was randomly assigned for each rat with the stipulation that each of the 5
doses would be administered before a dose was repeated. Thus, each rat received each dose
4 times over the 20 nicotine sessions. For both groups, there were 36 deliveries of 26% (w/
v) sucrose (4 s each) on nicotine sessions. The first sucrose delivery of the session ranged
from 124 to 152 s with an average of 137 s; subsequent sucrose deliveries were presented on
average every 25 s (range = 4 to 80 s). On saline sessions, rats in both groups received a SC
saline injection 5 min before placement in the chamber; sucrose was withheld during saline
sessions.
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2.4 Extinction
Starting 24 hours after the last acquisition day were 8 daily extinction sessions. For all rats,
extinction sessions consisted of a 0.2 mg/kg nicotine injection (SC) 5 min before a 20-min
session in which no sucrose was available. The 0.2 mg/kg dose was chosen as it was the
training dose for the StD group and the average of all the doses for the VD group. For
extinction, one might expect greater persistence of responding in the StD group because they
had an appetitive conditioning history consisting of 20 sessions with the 0.2 mg/kg dose
(i.e., the extinction dose). In contrast, the VD group received the 0.2 mg/kg dose of nicotine
on just 4 of the 20 conditioning sessions. The remaining 16 conditioning sessions may
involve different neuropharmacological (stimulus) elements from the 0.2 mg/kg extinction
dose (Polewan et al, 2013).
2.5 Nicotine Challenge
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On the day following the last extinction session, all rats were given nicotine challenge tests.
During the challenge, rats were administered 0.35 mg/kg nicotine before a 20-min session in
the conditioning chamber with no sucrose available. The 0.35 mg/kg dose was selected
because it was the highest dose in the set of nicotine stimuli given to the VD group and it
may differ in its neuropharmacological (stimulus) elements from the extinguished 0.2 mg/kg
dose. If so, we expect conditioned responding to increase more in group VD when tested
with the 0.35 mg/kg dose of nicotine. Challenge sessions occurred daily for 3 consecutive
days.
2.6 Reacquisition
Rats were then retrained for 10 reacquisition sessions (5 nicotine and 5 saline). Sessions
were identical to those during acquisition. The StD group once again received 0.2 mg/kg
before each nicotine session, whereas each rat in the VD group received 0.05, 0.125, 0.2,
0.275, and 0.35 mg/kg nicotine in a random order.
2.7 Nicotine Generalization Tests
Following reacquisition, a nicotine generalization curve was generated. Testing occurred on
the 5th day of a 5 day cycle. On days 1 to 4 of the cycle, rats received 2 standard nicotine
Pharmacol Biochem Behav. Author manuscript; available in PMC 2014 December 01.
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and 2 standard saline sessions. The nicotine dose for the StD group remained 0.2 mg/kg,
whereas the dose for the VD group continued to receive a dose from the set of doses; order
was again randomly assigned. To qualify for testing, rats had to meet the following criteria
on days 1-4 of the cycle: dipper entries before the first sucrose delivery on each nicotine
session must be 0.01 entries/sec higher than dipper entries during an equivalent amount of
time on both saline days (Besheer et al, 2004). If a rat did not reach criteria, then it remained
in the home cage on the test day. If criteria were met, rats received an injection of nicotine
[0.0 (saline), 0.0125, 0.025, 0.05, or 0.1] 5 min before a 4-min test session. Dose order was
randomly assigned. No sucrose was available in the chamber during test sessions. When a
rat completed its generalization curve, it continued receiving standard conditioning sessions
on days 1 to 4 of the cycle, but remained in its home cage on day 5. Testing continued until
all rats had been tested with all 5 doses of nicotine.
2.8 Mecamylamine Antagonism of 0.2 mg/kg Nicotine
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Following completion of nicotine generalization testing, we assessed how readily the
stimulus effects of nicotine could be blocked by mecamylamine, a central and peripheral
nicotinic acetylcholine receptor (nAChR) antagonist (Martin et al, 1989). The testing cycle
was identical to that during nicotine generalization testing, with one exception. On test days,
a dose of mecamylamine [0.0 (saline), 0.1, 0.25, 0.5, 0.75, or 1.0 mg/kg] was given 20 min
before a 0.2 mg/kg injection of nicotine. Training and testing cycles were again conducted
until all rats had been tested with the 5 doses of mecamylamine.
2.9 Mecamylamine Antagonism of 0.1 mg/kg Nicotine
Following completion of the previous phase, rats were tested for mecamylamine blockade of
the stimulus effects of nicotine using a lower dose of nicotine; procedures were identical to
those during the first mecamylamine antagonism tests except a 0.1 mg/kg dose of nicotine
was used on test days.
2.10 Dependent Measures
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Head entries into the recessed sucrose receptacle (i.e., dipper entries) were recorded on all
sessions. A rate measure of dipper entries per sec before the first sucrose presentation (or an
equivalent amount of time for saline sessions) was calculated for acquisition. Using only
dipper entries before any access to sucrose avoids any influence of sucrose exposure on this
measure of learning. During acquisition, the primary dependent measure was a dipper
entries per sec difference score. This measure was calculated by subtracting dipper entries
per sec during the saline session from dipper entries per sec during the corresponding
nicotine session. The dependent measure for generalization and antagonist tests was total
dipper entries during the 4-min test.
2.11 Statistical Analysis
In acquisition and reacquisition, dipper entries difference scores were analyzed with twoway repeated measure analysis of variance (ANOVAs) with Group (StD vs. VD) as a
between-subjects factor and Session as the repeated measure. To check for discrimination
between nicotine vs. saline sessions in acquisition and reacquisition, dipper entries per sec
were analyzed with a two-way within-subjects repeated measure analysis of variance
(ANOVA) with Drug (nicotine vs. saline) as a within-subjects factor and Session as the
repeated measure for both groups. Total dipper entries during extinction and nicotine
challenge (20-min sessions) were again analyzed by two-way repeated measures ANOVAs
with Group as the between-subjects factor and Session as the repeated measure.
Generalization and antagonism tests were analyzed by two-way repeated measures
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3. Results
3.1 Acquisition
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Figure 1A shows the mean (± SEM) dipper entries per sec differences scores, as well as
individual values across acquisition. Individual data are displayed to reveal the range of
values with in each group. Data analysis revealed a significant main effect of Session
[F(19,266)=8.28, p<0.001], but there was no main effect of Group or Group × Session
interaction (Fs<1) indicating that acquisition of the discrimination did not differ between
groups that were trained with a varying or constant dose of nicotine. Figure 1B shows the
dipper entries during saline and nicotine sessions in acquisition for the StD group. There was
main effects of Drug [F(1,19)=44.38, p<0.001] and Session [F(19,266)=3.62, p<0.001], as
well as a significant Drug × Session interaction [F(19,266)=3.87, p<0.001]. Post-hoc tests
revealed a significant increase in responding following administration of nicotine (compared
to saline) on sessions 6 to 8 and 10 to 20. Figure 1C shows the dipper entries for the saline
and nicotine sessions for the VD group. There was again main effects of Drug
[F(1,19)=64.43, p<0.001] and Session [F(19,266)=2.52 p<0.001], as well as a significant
Drug × Session interaction [F(19,266)=2.93, p<0.001]. Conditioned responding following
nicotine administration was significantly increased on session 8 and 9, 11, 13 to 15 and 17 to
20.
3.2 Extinction
Figure 2A shows total dipper entries across extinction sessions with 0.2 mg/kg nicotine.
There was a main effect of Session [F(7,90)=27.81, p<0.001] indicating a decrease in
conditioned responding across sessions. The main effect of Group [F(1,7)=1.13, p=0.30] and
the Group × Session interaction were not significant [F<1]. This data pattern indicates that
the persistence of responding in the absence of the sucrose reinforcer was not affected by
whether the training dose was constant or variable.
3.3 Nicotine Challenge
Figure 2B shows total dipper entries during the nicotine challenge with 0.35 mg/kg nicotine.
There was a main effect of Session [F(2,28)=10.31, p<0.001], but the main effect of Group
and the Group × Session interaction were not significant [Fs<1].
3.4 Reacquisition
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Analysis of differences scores for reacquisition (data not shown) revealed a main effect of
Session [F(4,56)=8.09, p<0.001]. There was no main effect of Group [F(1,4)=2.83, p=0.11]
or Group × Session interaction [F<1] indicating comparable reacquisition between the
groups. Examination of dipper entries for the StD group showed significant main effects of
Drug [F(1,4)=41.32, p<0.001] and Session [F(4,56)=3.29, p<0.1], as well as a significant
interaction [F(4,56)=2.59, p<0.05], with nicotine session responding (compared to saline)
significantly higher on all reacquisition sessions. Analysis of dipper entries for the VD
group also found significant main effects of Drug [F(1,4)=39.42, p<0.001], Session
[F(4,56)=3.57, p<0.01], and a significant interaction [F(4,56)=4.04, p<0.01], with nicotineevoked responding significantly higher on reacquisition sessions 3 to 5.
3.5 Nicotine Generalization
Figure 3A shows total dipper entries during nicotine generalization tests. Analysis revealed a
main effect of Dose [F(4,56)=17.31, p<.001], but no effect of Group and no significant
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Group × Dose interaction [Fs<1]. The 0.1 mg/kg nicotine dose evoked significantly more
responding than 0 (saline), 0.0125, 0.025, or 0.05 mg/kg nicotine. The 0.05 mg/kg nicotine
dose evoked responding significantly higher than the 0 (saline) or 0.0125 mg/kg nicotine.
3.6 Mecamylamine Antagonism of 0.2 mg/kg Nicotine
Figure 3B shows total dipper entries during mecamylamine antagonism of 0.2 mg/kg
nicotine. There was a main effect of mecamylamine Dose [F(5,70)=7.04, p<0.001]
indicating a dose-dependent blockade of conditioned responding by mecamylamine. There
was no main effect of Group or Group × Dose interaction [Fs<1]. Post-hoc analyses on the
main effect of Dose revealed that pretreatment with 0.75 and 1 mg/kg mecamylamine
significantly decreased nicotine-evoked responding compared to saline pretreatment.
Mecamylamine was not tested alone in this study. However, previous published research
from our lab has demonstrated that mecamylamine does not alter general chamber activity,
making a motor impairment account for the reduction in goal-tracking here unlikely
(Besheer et al, 2004; Struthers et al, 2009; Wilkinson et al, 2010).
3.7 Mecamylamine Antagonism of 0.1 mg/kg Nicotine
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Figure 3C shows total dipper entries during mecamylamine antagonism of 0.1 mg/kg
nicotine. Again, there was a significant main effect of mecamylamine Dose [F(5,70)=9.15,
p<0.001], but there was no effect of Group and no Group × Dose interaction [Fs<1]. Posthoc analyses on the main effect of Dose revealed that pretreatment with 0.5, 0.75, and 1 mg/
kg mecamylamine significantly decreased nicotine-evoked responding compared to the 0
(saline).

4. Discussion
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Elucidating the role of learning involving the interoceptive stimulus effects of drugs is
needed for a more comprehensive understanding of addiction (Bevins et al, 2012; Bevins et
al, 2011; Glautier et al, 1996; Stolerman et al, 2011). The present study investigated how
utilizing a class (set) of nicotine stimuli would affect interoceptive conditioning relative to a
group that had the same nicotine dose throughout training. To do so, one group of rats with a
range of nicotine doses (0.05, 0.125, 0.2, 0.275, and 0.35 mg/kg) and a second group with a
fixed dose (0.2 mg/kg) were trained using the nicotine discriminated goal-tracking task.
Acquisition of goal-tracking was similar between groups, with both groups discriminating
between saline and nicotine. In concordance with previous studies in our laboratory, the
nicotine stimulus was sensitive to non-reinforcement, showing attenuated responding across
extinction sessions (Besheer et al, 2004; Murray et al, 2007b; Reichel et al, 2010; Struthers
et al, 2009; Wilkinson et al, 2006). This extinction with 0.2 mg/kg transferred to a higher
dose of nicotine (0.35 mg/kg). A similar result was found by Polewan et al. (2013) using a
0.4 mg/kg training dose. As in previous studies, stimulus control over conditioned
responding was dose-dependent; higher doses of nicotine evoked increased goal-tracking
relative to the lower doses (Besheer et al, 2004; Murray et al, 2007a, b; Murray et al, 2009c;
Reichel et al, 2007; Reichel et al, 2010; Struthers et al, 2009). Further, mecamylamine dosedependently blocked goal-tracking evoked by 0.2 and 0.1 mg/kg nicotine; as mecamylamine
dose increased, goal-tracking decreased. The 0.1 mg/kg dose of nicotine was blocked by a
lower dose of mecamylamine, suggesting that the salience or perceptibility was lower for the
0.1 mg/kg dose than the 0.2 mg/kg dose. This extends previous research that used
mecamylamine to block responding evoked by 0.4 mg/kg nicotine (Besheer et al, 2004;
Murray et al, 2007b; Murray and Bevins, 2009a; Struthers et al, 2009) and research that
blocked goal-tracking by an intravenous nicotine stimulus (Murray et al, 2009a). The data
pattern across these tests was similar regardless of training condition (i.e., group StD vs.
group VD). This similarity suggests that under the current experimental protocol using a
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constant versus a varying dose of nicotine, variation of the dose did not produce a difference
in interoceptive conditioning or our testing procedures were not sufficiently sensitive to
detect existing differences.
Research on the categorization of stimuli in animal models predicts that differences should
occur when a set or class of stimuli are used (Bhatt, 1988; Herrnstein, 1979; Herrnstein and
deVillers, 1980a; Herrnstein et al, 1964; Siegel et al, 1970; Stemmer, 1980; Wasserman and
Bhatt, 1992a; Watanabe et al, 1995). In general, as the number of stimuli in a category
increases, acquisition is retarded and generalization during transfer (cf. substitution tests)
tests is improved. This effect is highlighted nicely by Bhatt’s work (1988). Three groups of
pigeons were trained to peck a corresponding key when shown a cat, car, flower, or chair.
One group was trained with a single example of each picture. A second group was trained
using 4 different exemplars of each category; the third group received 12 different pictures
of each category. The group that trained using only a single picture demonstrated the
quickest acquisition of correct key choice and was the most accurate. However, this single
picture group displayed poor generalization to new pictures of cats, cars, flowers, and chairs
(Bhatt, 1988; Wasserman et al, 1992a). In contrast, the group trained with 12 examples of
each category exhibited significant retardation of acquisition, but there was better
generalization when tested with novel pictures (Wasserman et al, 1992a).
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The brief discussion of research with classes of exteroceptive stimuli in the previous
paragraph begs the question of why a similar outcome did not occur here. If the reason lies
with the protocol not producing difference in interoceptive conditioning, then the possible
parametric manipulations are numerous. Perhaps there were not enough exemplars. Maybe
the dose range was too narrow (i.e., go higher than 0.35 mg/kd). Or, the training should have
continued much longer before testing. Maybe more non-reinforced stimuli are needed; recall
that only saline was used. Or, the nicotine stimuli used were too close together. Perhaps
using less optimal training parameters (e.g., fewer sucrose deliveries per session) would
reveal differences. If the reason lies with insensitivity of testing procedures, then alternative
protocols could also be used in future research. For example, a more selective antagonist
could be used such as DhβE (Struthers et al, 2009). Rather than antagonist tests, perhaps
substitution tests with ligands that share some of the neurobiological stimulus elements with
nicotine would reveal differences (Reichel et al, 2010).
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When reflecting on potential reasons and future experiments, one should keep in mind the
qualities of interoceptive drug stimuli that might pose design challenges (Bevins & Murray,
2011; Bevins et al., 2012). A pharmacological stimulus is often quite complex, differing
somewhat from more traditional, discrete, exteroceptive cues such as lights or tones. When
nicotine is administered, pharmacokinetic processes begin to distribute nicotine throughout
the body—central and peripheral receptors are affected. Metabolic processes also start,
eventually resulting in excretion of nicotine and its metabolites from the body. Note that the
effect of a drug peripherally or centrally will further depend on complex pharmacodynamic
processes (Brunzell and Picciotto, 2009; Placzek and Dani, 2009). Combined, these
processes are affecting what the perceptible interoceptive nicotine stimulus may be over
time. So, the 0.2 mg/kg dose administered to the StD group is experimentally fixed (i.e., the
same dose administered each nicotine session), yet the perceptible interoceptive effects of
nicotine are, in practice, varying. With this notion in mind, the 0.o5 and 0.125 mg/kg
nicotine stimulus of the VD group, albeit not paired with sucrose for entire sessions, would
at least be presented to the StD group on every nicotine training session. Thus, the StD
group, like the VD group, was presented with a set of stimuli; the set was just not as large as
it did not include the higher nicotine doses.
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This analysis has empirical support from a series of clever studies by Siegel and his
colleagues. In those studies, they established that early interoceptive drug stimuli differ from
the latter cues and that these early onset stimuli can function as a signal for later onset of the
primary drug effect and evoke a compensatory conditioned response (Kim et al, 1999;
Siegel, 2005; Siegel et al, 2002). The finding, for example, that a low dose of morphine can
acquire control over a conditioned analgesic response opposing that of the higher dose (Kim
et al, 1999) is important for the present discussion. That is, it provides support for the idea
that a low dose of a drug has different stimulus effects than a higher dose of the same drug
and that these stimuli are discriminably different as evidence by control of different
behavior. Similar support for nicotine from the discriminated goal-tracking task was
discussed in the Introduction (e.g., Murray et al, 2007b; Polewan et al, 2013). Additional
support from within the drug discrimination literature comes from research with a drug
mixture such as midazolam plus nicotine (Mariathasan et al, 1993; Stolerman et al, 1996;
White et al, 1996). Under appropriate testing conditions, acquired control over behavior for
the “midazolam-like” stimulus element can be separated from those of the “nicotine-like”
stimulus elements.

NIH-PA Author Manuscript

Early on, Pavlov (1927) recognized the import of conditioning involving interoceptive
stimuli to diseases and psychopathologies. For addiction, drug effects are an obvious and
important source of interoceptive stimuli. Other sources may include interoception related to
withdrawal, stress, cognitive deficits, etc. (Koob, 2004). Continued efforts to better
understand the role of learning involving interoceptive stimuli are needed for a more
comprehensive theory of drug addiction (Bevins et al, 2011; Bevins et al, 2004; Paulus and
Stewart, 2013; Wise et al, 2008) and improved intervention and prevention approaches
(Alessi et al, 2002; Clements et al, 1996; Glautier et al, 1996).
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Rats had discrimination training with 1 or 5 nicotine doses.
Both groups learned the discrimination and showed a typical extinction pattern.
Extinction transfers to a higher nicotine dose and mecamylamine blocked
responding.
No differences in performance were found between the two groups.
The results may be attributable to the unique qualities of a drug stimulus.
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Figure 1.

Panel A shows dipper entry rate differences scores between nicotine and saline days during
acquisition [individual and mean scores (± SEM) shown]. A score of 0 (solid line) would
represent no difference of responding between nicotine and saline days for the session. Panel
B shows dipper entries per second (±SEM) before the first sucrose delivery (nicotine
sessions) or during a comparable time (saline sessions) for the StD group. Panel C shows
dipper entries per second (±SEM) before the first sucrose delivery (nicotine sessions) or
during a comparable time (saline sessions) for the VD group. * denotes significant
differences (p<o.05) between the nicotine and saline days in a session.
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Figure 2.

Panel A shows mean (± SEM) and individual total dipper entries during extinction. Panel B
shows mean (± SEM) and individual total dipper entries during nicotine challenge tests with
0.35 mg/kg nicotine. The solid and dotted line represent responding during the final
extinction session for VD and STD group respectively.
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Figure 3.

Panel A displays mean (±SEM) and individual dipper entries during nicotine generalization
testing. Panel B shows mean (±SEM) and individual total dipper entries during nAChR
antagonism of a 0.2 mg/kg dose of nicotine. Panel C shows mean (±SEM) and individual
total dipper entries during nAChR antagonism of a 0.1 mg/kg dose of nicotine.
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